Le Lézard
Classified in: Health, Science and technology, Business
Subjects: HSP, BLK, CXP

Microbiologics expands virology capabilities for SARS-CoV-2 with new BSL-3 laboratory at its San Diego facility


SAN DIEGO, Aug. 3, 2020 /PRNewswire/ -- Microbiologics announced today that it has recently completed renovations of the virology services laboratory in its San Diego location. With completion of the renovation, Microbiologics has expanded its custom virology solutions to include Biosafety Level 3 (BSL-3) antiviral services. With these new capabilities, Microbiologics has launched a menu of cell-based services for SARS-CoV-2 to assist assay developers, evaluate therapeutic solutions and vaccines, and provide inactivated intact virus to researchers and diagnostic companies.

Microbiologics has also expanded its viral capabilities to include reverse genetics systems to create recombinant viruses, increased in-vitro assay capabilities, including cytopathic effect screening, hemagglutination-inhibition testing (HAI), neutralization assays, and yield-reduction assays. The newly renovated space also allows for increased capacity for viral propagation of high-titer stock materials. Microbiologics has also recently completed its process for ISO 13485 accreditation at the San Diego Facility.

Additional information about the complete virology services offered at Microbiologics is available by email at [email protected].

Visit microbiologics.com/virology to learn more.

About Microbiologics

Microbiologics, the leading global provider of infectious disease biomaterials. Microbiologics has provided clinical, food, water, pharmaceutical and cosmetic laboratories with reliable, ready-to-use microbial reference materials for nearly 50 years. The company has a distribution network that reaches more than 140 countries worldwide.

Microbiologics acquired San Diego based Virapur in 2017 expanding its research and development support services to therapeutics, vaccines and gene therapy, as well as broaden its viral molecular controls portfolio.

Karin Pauly
Microbiologics
1.800.599.2847
[email protected]

 

SOURCE Microbiologics


These press releases may also interest you

at 08:35
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Schrödinger, Inc. , whose physics-based computational platform is transforming the way therapeutics and materials are discovered, today reported that on April 15, 2024, the company granted (i) non-statutory stock options to purchase 3,600 shares of...

at 08:35
RenovoRx Regains Compliance with Nasdaq Stockholders' Equity Requirement
RenovoRx, Inc. ("RenovoRx" or the "Company") , a clinical-stage biopharmaceutical company developing novel precision oncology therapies based on a local drug-delivery platform, today announced that, in light of its recent successful fundraising...

at 08:35
Cerus Corporation to Release First Quarter 2024 Financial Results on May 2, 2024
Cerus Corporation announced today that its first quarter 2024 financial results will be released on Thursday, May 2, 2024, after the close of the stock market. The Company will host a conference call and webcast at 4:30 P.M. ET that afternoon,...

at 08:34
GIST Scientists Navigate the Paradox of Extreme Cold Events in a Warming World
According to Copernicus Climate Change Service, February 2024 was the warmest February ever recorded globally. However, North America, Asia, and parts of Europe experienced record-breaking cold temperatures. In some places, such as China's Mohe and...

at 08:32
NRx Pharmaceuticals (NASDAQ:NRXP) Receives Notice from Nasdaq that the Company has Demonstrated Compliance with the Bid Price Requirement
...

at 08:32
Easterseals Midwest Selects Core Solutions Cx360 EHR
Core Solutions, Inc., (Core) is pleased to announce that Easterseals Midwest has selected its Cx360 electronic health record (EHR) solution. This selection reflects the organization's ongoing commitment to helping individuals with intellectual and...

More news about Science and technology...


News published on and distributed by: